Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantationPeter J. Darlington, Denis Gaucher, Joumana Zeidan et al.|Annals of Neurology|2012Cited by 152
Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple SclerosisPeter J. Darlington, Amit Bar‐Or, Brandon Stopnicki et al.|Frontiers in Immunology|2018Cited by 77